Articles & Press Releases

Looking into job opportunities? Just want to see what’s out there in terms of career moves to another part of the country?

BY MATTHEW SIDEMAN, MD AND SUNITA SRIVASTAVA, MD

BY PETER CONNOLLY, MD, AND MARK MATTOS, MD

Imagine that you are telling your lay friends about what you do for a living. You have to explain the difference between arteries and veins. And then you find that you need to clarify that you do not, in fact, operate on the heart.

BY BETH BALES

Decades ago, “picture” phones were an idea straight out of science fiction.

As the saying goes, the future is now. FaceTime and Skype are common; similar technology permits doctors to visit patients via telemedicine.

The Journal of Vascular Surgery (JVS) and JVS: Venous and Lymphatic Disorders (JVS-VL) have a number of open-source articles available in the April and May issues. A sampling follows.

BY BETH BALES

The Global Vascular Guidelines (GVG), extensively researched and written by an international committee of leading vascular experts, are now available as a pocket guide.

BY BETH BALES

Helping vascular trainees successfully transition from education and training to clinical or academic practice is the central goal for the Vascular Trainee Program at the 2020 Vascular Annual Meeting (VAM).

ROSEMONT, Ill., March 9, 2020 – Women’s heart health takes center stage as American Heart Month ends and National Women’s History Month and International Women’s Day are observed. The Society for Vascular Surgery shares the latest news on what women — and the people who love them —­ should know. Vascular surgeons are specialists who treat conditions of the vascular system, which impact heart health.

BY MALACHI SHEAHAN III, MD

Much has been made of the impending shortage of physicians in the United States, with worrying predictions that it could be as soon as 2030. The driving force is a rising, aging population and an upsurge in chronic disease such as diabetes and obesity.

BY JAMES ELMORE, MD

Mission, vision and strategy are necessary to develop a cutting-edge vascular surgery program. To maintain such a program, one needs to implement an overall long-term strategic plan, as well as meticulously oversee the administration of day-to-day details.

Get ready for another “Spectacular” evening at the 2020 Vascular Annual Meeting (VAM).

Ticket sales began in February for the second annual Society for Vascular Surgery (SVS) Foundation “Vascular Spectacular Gala: Northern Lights.”

The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) teamed up to release new reporting standards in order to ensure patients with type B aortic dissections (TBADs) receive appropriate treatment and care.

With significant progress made on many fronts in 2019, the Society for Vascular Surgery (SVS) is looking forward to the next horizon in 2020.

While I may be the Society for Vascular Surgery (SVS) Political Action Committee (PAC) chair, I find I still need a refresher from time to time regarding the members of Congress serving on committees that deal with healthcare issues where the SVS PAC needs to dedicate the most time and resources. So, as the second session of the 116th Congress is now getting into full swing, I wanted to share information on the three major committees that deal with healthcare policies influenced by the legislative process.

Drugs and therapies that target immune cells and pathways within the body already exist to fight a number of diseases. Can vascular disease join the list?

Registration and housing for the 2020 Vascular Annual Meeting (VAM) are now open.

BY GREGORY KASPER, MD

A large, single-center study published in the March edition of the Journal of Vascular Surgery highlights the limitations of using the resting ankle-brachial index (ABI) in the diagnosis of symptomatic peripheral arterial disease (PAD), particularly in those with diabetes mellitus (DM) and chronic kidney disease (CKD).

Postpartum women undergoing catheter-directed thrombolysis and stenting for acute iliofemoral deep vein thrombosis (DVT) may be more likely to suffer stent occlusion and require reintervention, according to a single-center review published in the March edition of the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVSVL).

The biology of vascular disease—including molecular mechanisms and the immune system—will take center stage on May 4 in Chicago at the 2020 Vascular Research Initiatives Conference (VRIC) meeting of the Society for Vascular Surgery (SVS).

Applications for the SVS Foundation’s Clinical Research Seed Grant program are due March 1.

This program is designed to spur interest and development of clinical investigators among SVS members, particularly junior members with limited prior experience as principal investigators. 

The Society for Vascular Surgery (SVS) investment in accelerating the growth of vascular surgeon-leaders has begun.

Some 25 SVS members have embarked on a six-month course in developing leadership skills, as the first cohort of the new SVS Leadership Development Program.

A registry to track management of new patients who are being treated medically for a number of vascular diseases has been launched by the Society for Vascular Surgery (SVS) Patient Safety Organization® and the Society for Vascular Medicine, in collaboration with the American Heart Association, fo